You have 9 free searches left this month | for more free features.

iNKT cells

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hepatocellular Carcinoma Trial in Beijing (iNKT Cells, PD-1, Regorafenib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • iNKT Cells
  • +2 more
  • Beijing, Beijing, China
    Beijing Youan Hospital,Capital Medical University
Jul 24, 2023

NSCLC, Small Cell Lung Cancer, Pancreas Cancer Trial in Shanghai (Infusion of iNKT cells and CD8+T cells)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • +5 more
  • Infusion of iNKT cells and CD8+T cells
  • Shanghai, Shanghai, China
    Shanghai Public Health Clinical Center
May 6, 2022

Allergic Rhinitis Due to Grass Pollen Trial in Lublin (Ismigen, Placebo)

Completed
  • Allergic Rhinitis Due to Grass Pollen
  • Lublin, Poland
    Department of Pulmonary Diseases and Children Rheumatology, Medi
Apr 2, 2022

Malignant Solid Tumor Trial in Shanghai (Infusion of iNKT cells)

Completed
  • Malignant Solid Tumor
  • Infusion of iNKT cells
  • Shanghai, China
    Shanghai Public Health Clinical Center, Fudan University
May 6, 2022

Relapsed/Refractory Multiple Myeloma Trial in Louisville, Boston (agenT-797)

Active, not recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Louisville, Kentucky
  • +2 more
Oct 21, 2022

Natural Killer T Cells ExpressingInvariant T Receptor :

Not yet recruiting
  • Systemic Lupus Erythematosus
  • Physiopathology
  • Blood sample
  • Tours, France
    University Hospital
May 12, 2023

Acute Lymphoblastic Leukemia, B-cell Lymphoma, Chronic Lymphocytic Leukemia Trial in Xuzhou (hCD19.IL15.CAR-iNKT)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • Xuzhou, Jiangsu, China
    The Affiliated hospital of Xuzhou medical University
Mar 24, 2021

Tumor, Solid Trial in United States (agenT-797, Approved ICIs)

Recruiting
  • Tumor, Solid
  • Los Angeles, California
  • +8 more
Oct 21, 2022

Advanced Solid Tumor Trial in Nijmegen (PRECIOUS-01)

Recruiting
  • Advanced Solid Tumor
  • Nijmegen, Gelderland, Netherlands
    Radboudumc
Oct 26, 2022

Acute Myeloid Leukemia in Remission, Lymphoma in Remission, Non-progressive Myeloproliferative Syndrome Trial in Belgium,

Recruiting
  • Acute Myeloid Leukemia in Remission
  • +5 more
  • Ex vivo capacities of CD4neg INkT expansion of the peripheral blood donor with the Predictor test
  • Antwerpen, Belgium
  • +21 more
Sep 27, 2021

Hepatocellular Carcinoma Trial in Beijing (biological, drug, procedure)

Unknown status
  • Hepatocellular Carcinoma
  • iNKT cells
  • +3 more
  • Beijing, Beijing, China
    Beijing Youan Hospital,Capital Medical University
Jul 5, 2019

Immunoregulatory T Lymphocytes Subtypes and Haematopoietic Stem

Active, not recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies
  • Recipients
  • Donors
  • Paris, France
    Hopital Necker
Nov 19, 2021

Molecular Basis of Food Allergy

Recruiting
  • Food Allergy
  • Eosinophilic Esophagitis
    • Philadelphia, Pennsylvania
      The Children's Hospital of Philadelphia
    Dec 16, 2021

    Systemic Sclerosis Trial in Poitiers (Blood test)

    Recruiting
    • Systemic Sclerosis
    • Blood test
    • Poitiers, France
      CHU poitiers
    Mar 1, 2022

    Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia Trial in Boston (Antithymocyte Globulin,

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +6 more
    • Boston, Massachusetts
    • +1 more
    Jan 25, 2022

    Patients Receiving Biotherapies Targeting IL-23/IL-17 Axis in

    Recruiting
    • Psoriasis
    • Blood sample
    • +2 more
    • Paris, Ile De France, France
      Lars ROGGE
    Oct 6, 2022

    Pancreatic Cancer Trial in Shanghai (Stereotactic body radiation therapy plus vNKT cell adoptive therapy)

    Recruiting
    • Pancreatic Cancer
    • Stereotactic body radiation therapy plus vNKT cell adoptive therapy
    • Shanghai, China
      Changhai Hospital affiliated to Naval Medical University
    Mar 13, 2023

    NSCLC, Melanoma Trial (IMM60, Pembrolizumab)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Melanoma
    • (no location specified)
    Jan 24, 2023

    Advanced Therapies for Liver Metastases

    Recruiting
    • Pancreatic Ductal Adenocarcinoma (PDAC)
    • +2 more
      • Milan, Italy
        IRCCS San Raffaele
      Aug 8, 2022

      Acute Myeloid Leukemia (AML) or Minimal Residual Disease (MRD Plus) Trial in Pessac, Paris (Human T Lymphoid Progenitor (HTLP)

      Recruiting
      • Acute Myeloid Leukemia (AML) or Minimal Residual Disease (MRD Plus)
      • Human T Lymphoid Progenitor (HTLP) injection
      • Pessac, France
      • +1 more
      Oct 28, 2021

      Lung Transplant Trial in Baltimore, Charlottesville (Regadenoson infusion)

      Unknown status
      • Lung Transplant
      • Regadenoson infusion
      • Baltimore, Maryland
      • +1 more
      Jun 3, 2020

      Melanoma (Skin) Trial in Los Angeles (CP-675,206)

      Completed
      • Melanoma (Skin)
      • CP-675,206
      • Los Angeles, California
        Jonsson Comprehensive Cancer Center at UCLA
      Oct 1, 2020

      Hepatocellular Carcinoma Trial in Beijing (iNKT cells, IL-2, Tegafur)

      Unknown status
      • Hepatocellular Carcinoma
      • iNKT cells
      • +2 more
      • Beijing, Beijing, China
        Beijing Youan Hospital,Capital Medical University
      Jan 17, 2018

      Anatomic Stage IV Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma Trial in Columbus (procedure, drug, biological)

      Not yet recruiting
      • Anatomic Stage IV Breast Cancer AJCC v8
      • HER2-Negative Breast Carcinoma
      • Biospecimen Collection
      • +5 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Aug 30, 2023

      Recurrent Multiple Myeloma, Refractory Multiple Myeloma Trial in Los Angeles (procedure, drug, other)

      Not yet recruiting
      • Recurrent Multiple Myeloma
      • Refractory Multiple Myeloma
      • Bone Marrow Aspiration
      • +10 more
      • Los Angeles, California
        Melanie Ayala Ceja
      Jul 10, 2023